0
     

Report Added
Report already added
Duchenne Muscular Dystrophy Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Duchenne Muscular Dystrophy Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20._x000D_
_x000D_
This report contains market size and forecasts of Duchenne Muscular Dystrophy in India, including the following market information:_x000D_
India Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)_x000D_
India Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)_x000D_
Top Five Competitors in India Duchenne Muscular Dystrophy Market 2019 (%)_x000D_
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)_x000D_
India Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)_x000D_
Deflazacort_x000D_
Prednisone_x000D_
Others_x000D_
_x000D_
India Duchenne Muscular Dystrophy Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Doses)_x000D_
India Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)_x000D_
Male_x000D_
Female_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Duchenne Muscular Dystrophy Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)_x000D_
Total India Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
PTC Therapeutics_x000D_
Sarepta Therapeutics_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Duchenne Muscular Dystrophy Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Duchenne Muscular Dystrophy Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Duchenne Muscular Dystrophy Overall Market Size_x000D_
2.1 India Duchenne Muscular Dystrophy Market Size: 2020 VS 2026_x000D_
2.2 India Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Duchenne Muscular Dystrophy Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Duchenne Muscular Dystrophy Companies Ranked by Revenue_x000D_
3.3 India Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Duchenne Muscular Dystrophy Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in India_x000D_
3.8.1 List of India Tier 1 Duchenne Muscular Dystrophy Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026_x000D_
4.1.2 Deflazacort_x000D_
4.1.3 Prednisone_x000D_
4.1.4 Others_x000D_
4.2 By Type - India Duchenne Muscular Dystrophy Revenue & Forecasts_x000D_
4.2.1 By Type - India Duchenne Muscular Dystrophy Revenue, 2015-2020_x000D_
4.2.2 By Type - India Duchenne Muscular Dystrophy Revenue, 2021-2026_x000D_
4.2.3 By Type - India Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Duchenne Muscular Dystrophy Sales & Forecasts_x000D_
4.3.1 By Type - India Duchenne Muscular Dystrophy Sales, 2015-2020_x000D_
4.3.2 By Type - India Duchenne Muscular Dystrophy Sales, 2021-2026_x000D_
4.3.3 By Type - India Duchenne Muscular Dystrophy Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Duchenne Muscular Dystrophy Market Size, 2020 & 2026_x000D_
5.1.2 Male_x000D_
5.1.3 Female_x000D_
5.2 By Application - India Duchenne Muscular Dystrophy Revenue & Forecasts_x000D_
5.2.1 By Application - India Duchenne Muscular Dystrophy Revenue, 2015-2020_x000D_
5.2.2 By Application - India Duchenne Muscular Dystrophy Revenue, 2021-2026_x000D_
5.2.3 By Application - India Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Duchenne Muscular Dystrophy Sales & Forecasts_x000D_
5.3.1 By Application - India Duchenne Muscular Dystrophy Sales, 2015-2020_x000D_
5.3.2 By Application - India Duchenne Muscular Dystrophy Sales, 2021-2026_x000D_
5.3.3 By Application - India Duchenne Muscular Dystrophy Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 PTC Therapeutics_x000D_
6.1.1 PTC Therapeutics Corporate Summary_x000D_
6.1.2 PTC Therapeutics Business Overview_x000D_
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings_x000D_
6.1.4 PTC Therapeutics Sales and Revenue in India (2015-2020)_x000D_
6.1.5 PTC Therapeutics Key News_x000D_
6.2 Sarepta Therapeutics_x000D_
6.2.1 Sarepta Therapeutics Corporate Summary_x000D_
6.2.2 Sarepta Therapeutics Business Overview_x000D_
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings_x000D_
6.2.4 Sarepta Therapeutics Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Sarepta Therapeutics Key News_x000D_
6.3 Others_x000D_
6.3.1 Others Corporate Summary_x000D_
6.3.2 Others Business Overview_x000D_
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings_x000D_
6.3.4 Others Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Others Key News_x000D_
_x000D_
7 Duchenne Muscular Dystrophy Production Capacity, Export and Import Analysis_x000D_
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Duchenne Muscular Dystrophy Production Capacity, 2015-2026_x000D_
7.1.2 India Duchenne Muscular Dystrophy Production 2015-2026_x000D_
7.1.3 India Duchenne Muscular Dystrophy Production Value 2015-2026_x000D_
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in India_x000D_
7.2.1 India Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Duchenne Muscular Dystrophy Manufacturers Production_x000D_
7.2.3 India Key Local Duchenne Muscular Dystrophy Manufacturers Production Value_x000D_
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Duchenne Muscular Dystrophy Export and Import in India_x000D_
7.3.1 India Duchenne Muscular Dystrophy Export Market_x000D_
7.3.2 India Duchenne Muscular Dystrophy Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Duchenne Muscular Dystrophy Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Duchenne Muscular Dystrophy Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Duchenne Muscular Dystrophy in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020_x000D_
Table 6. India Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)_x000D_
Table 8. India Manufacturers Duchenne Muscular Dystrophy Product Type_x000D_
Table 9. List of India Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Duchenne Muscular Dystrophy Sales in India (K Doses), 2015-2020_x000D_
Table 14. By Type - Duchenne Muscular Dystrophy Sales in India (K Doses), 2021-2026_x000D_
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Duchenne Muscular Dystrophy Sales in India, (K Doses), 2015-2020_x000D_
Table 18. By Application - Duchenne Muscular Dystrophy Sales in India, (K Doses), 2021-2026_x000D_
Table 19. PTC Therapeutics Corporate Summary_x000D_
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings_x000D_
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 22. Sarepta Therapeutics Corporate Summary_x000D_
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings_x000D_
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 25. Others Corporate Summary_x000D_
Table 26. Others Duchenne Muscular Dystrophy Product Offerings_x000D_
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in India, 2015-2020_x000D_
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in India, 2015-2020_x000D_
Table 30. India Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 32. India Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 36. Raw Materials and Suppliers_x000D_
Table 37. Duchenne Muscular Dystrophy Downstream Clients in India_x000D_
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Duchenne Muscular Dystrophy Segment by Type_x000D_
Figure 2. Duchenne Muscular Dystrophy Segment by Application_x000D_
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Duchenne Muscular Dystrophy Market Size in India, (US$, Mn) & (K Doses): 2020 VS 2026_x000D_
Figure 6. India Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Duchenne Muscular Dystrophy Sales in India: 2015-2026 (K Doses)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019_x000D_
Figure 9. By Type - India Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Duchenne Muscular Dystrophy Market Share, 2015-2020_x000D_
Figure 11. By Type - India Duchenne Muscular Dystrophy Market Share, 2020-2026_x000D_
Figure 12. By Type - India Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026_x000D_
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Duchenne Muscular Dystrophy Market Share, 2015-2020_x000D_
Figure 15. By Application - India Duchenne Muscular Dystrophy Market Share, 2020-2026_x000D_
Figure 16. By Application -India Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026_x000D_
Figure 17. India Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026_x000D_
Figure 18. India Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026_x000D_
Figure 19. India Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Duchenne Muscular Dystrophy Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Duchenne Muscular Dystrophy, 2019_x000D_
Figure 22. PEST Analysis for India Duchenne Muscular Dystrophy Market in 2020_x000D_
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in India_x000D_
Figure 24. Duchenne Muscular Dystrophy Market Drivers in India_x000D_
Figure 25. Duchenne Muscular Dystrophy Market Restraints in India_x000D_
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Duchenne Muscular Dystrophy Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW